Philips is set to report its second-quarter results on July 28th, and analysts at Bernstein are warning that profit margins will likely take a hit from rising costs. The Dutch health technology company faces headwinds from inflation and new tariffs, which are squeezing margins now, even as management’s longer-term targets for 2026 remain within reach.
What’s behind the margin pressure?
Bernstein expects Philips’ adjusted EBITA margin — a measure of operating profit before certain one-off items — to decline compared to the same period last year. The culprit is a familiar one for many global manufacturers: higher input costs from inflation and the impact of tariffs on imported components and finished goods. These cost pressures are hitting Philips’ bottom line in the near term, while the company’s countermeasures — such as raising prices, shifting suppliers, and cutting costs — are only expected to start showing results later in the year.
This timing mismatch is a key theme for the quarter. As Bernstein notes, the fixes are “back-end loaded,” meaning investors will have to wait for the second half of 2025 to see meaningful margin improvement. That dynamic is similar to what other industrial and consumer goods companies have faced recently, as supply chain disruptions and trade policy changes create a lag between cost increases and the benefits of mitigation efforts. For more on how margin pressures are playing out across sectors, see our coverage of Topps Tiles’ warning on heatwave and demand.
Demand side looks brighter
On the revenue front, the picture is more encouraging. Bernstein expects Philips’ second-quarter sales growth to come in near the top end of the company’s own guidance range. That optimism is supported by easier year-over-year comparisons and improving momentum across Philips’ key businesses, including its diagnostic imaging, personal health, and connected care divisions.
This suggests that underlying demand for Philips’ products — from hospital equipment to electric toothbrushes — remains solid, even as the company navigates a challenging cost environment. The contrast between strong top-line growth and squeezed margins is a classic sign of a company in transition, where short-term pain is being absorbed to set up a stronger future.
What it means for investors
Bernstein has trimmed its 2026 earnings-per-share forecast for Philips by 1%, partly due to currency fluctuations, but has kept its “market-perform” rating and 25.40-euro price target unchanged. That’s a notable signal: when an analyst cuts earnings estimates but leaves the price target intact, the implied valuation multiple rises. In plain terms, Bernstein is betting that investors will be willing to pay a higher price for each euro of future profit, because they believe the current margin squeeze is temporary.
This puts a lot of weight on the July 28th update. If Philips’ management can convince the market that the cost pressures are short-lived and that the recovery path to 2026 is on track, the unchanged target makes sense. But if the earnings call reveals that the margin pressure is deeper or more persistent than expected, the valuation cushion could quickly disappear. For context on how other companies are handling similar margin tests, see our analysis of Knight-Swift’s margin challenges in freight.
Broader context: inflation, tariffs, and corporate margins
Philips is far from alone in facing this kind of squeeze. Across the global economy, companies are grappling with the aftereffects of post-pandemic inflation and a wave of new trade barriers. The European Central Bank has been raising interest rates to cool inflation, which adds another layer of cost pressure for companies with debt. Meanwhile, tariffs — particularly those imposed by the U.S. on Chinese goods — are raising costs for manufacturers that rely on global supply chains.
For Philips, which has a significant presence in both Europe and the U.S., these forces are converging in the second quarter. The company’s ability to pass on higher costs to customers through pricing will be a key factor in whether it can protect margins over the longer term. Investors will also be watching for any signs that the tariff environment is easing or that Philips is making progress on its cost-cutting initiatives.
Currency movements add another layer of complexity. A strong U.S. dollar can hurt European exporters like Philips by making their products more expensive in dollar-denominated markets. Bernstein’s 1% EPS cut partly reflects currency headwinds, a reminder that exchange rates matter for multinational companies. For more on how currency pressures are affecting markets, see our piece on the strong dollar’s impact on Latin American markets.
Looking ahead: what to watch on July 28th
When Philips reports, investors should focus on three things: first, the actual Q2 EBITA margin and how it compares to last year and to Bernstein’s expectations; second, management’s commentary on the timing and effectiveness of its mitigation strategies; and third, any updates to the 2026 financial targets. If the company reaffirms its long-term goals while acknowledging near-term pain, that would align with Bernstein’s view. If it starts to waver on the 2026 targets, the stock could face a reassessment.
For now, the market appears to be giving Philips the benefit of the doubt. The unchanged price target from Bernstein suggests that the analyst firm sees the current margin weakness as a bump in the road, not a detour. But as with any earnings season, the proof will be in the numbers — and in the story management tells about the quarters ahead.
